Effect of IVIgG treatment on fetal platelet count, HPA-1a titre and clinical outcome in a case of feto-maternal alloimmune thrombocytopenia.
Lucas
G F
GF
International Blood Group Reference Laboratory, Bristol, UK.
Hamon
M
M
Carroll
S
S
Soothill
P
P
D016824:Antigens, Human Platelet / Q000032:analysis*; D001327:Autoimmune Diseases / Q000628:therapy*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005331:Fetomaternal Transfusion; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D039661:Integrin beta3; D010976:Platelet Count; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D011256:Pregnancy Outcome; D013921:Thrombocytopenia / Q000097:blood / Q000628:therapy*
D016824:Antigens, Human Platelet; C061248:ITGB3 protein, human; D016756:Immunoglobulins, Intravenous; D039661:Integrin beta3